National Health Investors, Inc. (NYSE:NHI – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings per share (EPS) estimates for shares of National Health Investors in a report released on Monday, March 17th. Wedbush analyst R. Anderson expects that the real estate investment trust will post earnings of $1.11 per share for the quarter. Wedbush currently has a “Outperform” rating and a $88.00 target price on the stock. The consensus estimate for National Health Investors’ current full-year earnings is $4.41 per share. Wedbush also issued estimates for National Health Investors’ Q2 2025 earnings at $1.16 EPS, Q3 2025 earnings at $1.18 EPS and Q4 2025 earnings at $1.21 EPS.
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 EPS for the quarter, topping the consensus estimate of $1.10 by $0.03. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $85.75 million for the quarter, compared to analyst estimates of $81.13 million.
Check Out Our Latest Report on National Health Investors
National Health Investors Trading Down 0.6 %
NYSE:NHI opened at $75.58 on Wednesday. National Health Investors has a 12 month low of $57.80 and a 12 month high of $86.13. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm’s 50 day moving average is $70.08 and its 200 day moving average is $74.68. The stock has a market capitalization of $3.45 billion, a PE ratio of 25.97, a price-to-earnings-growth ratio of 4.42 and a beta of 1.08.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the business. Norges Bank purchased a new position in National Health Investors during the 4th quarter valued at about $42,322,000. Millennium Management LLC grew its position in National Health Investors by 1,967.0% during the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock valued at $33,843,000 after acquiring an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. purchased a new position in National Health Investors in the 4th quarter worth $23,917,000. Marshall Wace LLP boosted its position in National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust’s stock valued at $38,225,000 after buying an additional 340,712 shares during the period. Finally, Zimmer Partners LP purchased a new stake in National Health Investors during the third quarter valued at about $25,218,000. 62.51% of the stock is owned by institutional investors.
National Health Investors Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Stockholders of record on Monday, March 31st will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 4.76%. The ex-dividend date of this dividend is Monday, March 31st. National Health Investors’s dividend payout ratio (DPR) is currently 115.38%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- How to Short a Stock in 5 Easy Steps
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Small Caps With Big Return Potential
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.